financetom
Business
financetom
/
Business
/
Market Chatter: Boeing Chief Executive Dave Calhoun Reelected to Board
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Market Chatter: Boeing Chief Executive Dave Calhoun Reelected to Board
May 17, 2024 9:47 AM

12:19 PM EDT, 05/17/2024 (MT Newswires) -- Boeing ( BA ) shareholders reelected outgoing Chief Executive Dave Calhoun to the company's board, CNBC reported Friday, citing a preliminary tally of votes.

Calhoun announced in March that he would step down from his management position by the end of 2024 following a string of incidents involving Boeing ( BA ) planes that have raised questions about the company's production and processes.

(Market Chatter news is derived from conversations with market professionals globally. This information is believed to be from reliable sources but may include rumor and speculation. Accuracy is not guaranteed.)

Price: 183.03, Change: +0.07, Percent Change: +0.04

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Starlight Investments Continues Expansion in UK Build-to-Rent Market with Strategic Acquisition in Maidenhead
Starlight Investments Continues Expansion in UK Build-to-Rent Market with Strategic Acquisition in Maidenhead
Oct 27, 2025
New acquisition from Vistry brings Starlight's UK rental housing portfolio to 4,000 homes TORONTO, Oct. 27, 2025 /PRNewswire/ - Starlight Investments, a leading global real estate investment and asset management firm, has announced the acquisition of a build-to-rent (BTR) development in Maidenhead, Berkshire. Forming part of the St Cloud Way regeneration scheme, the property was acquired from Countryside Properties...
Intellia Therapeutics Pauses Dosing in Phase 3 Trials After Grade 4 Liver Transaminases Reported in Participant
Intellia Therapeutics Pauses Dosing in Phase 3 Trials After Grade 4 Liver Transaminases Reported in Participant
Oct 27, 2025
08:01 AM EDT, 10/27/2025 (MT Newswires) -- Intellia Therapeutics ( NTLA ) said Monday it has paused patient dosing and screening for its two phase 3 clinical trials of nex-z for patients with transthyretin amyloidosis with cardiomyopathy and polyneuropathy, respectively, after a patient was reported with Grade 4 liver transaminases and increased total bilirubin after dosage with the drug. The...
Johnson & Johnson Says 2-Year Data for Tremfya in Crohn's Disease Shows Durable Remission
Johnson & Johnson Says 2-Year Data for Tremfya in Crohn's Disease Shows Durable Remission
Oct 27, 2025
08:01 AM EDT, 10/27/2025 (MT Newswires) -- Johnson & Johnson ( JNJ ) said Monday that long-term extensions of its phase 3 studies showed that its drug, Tremfya, maintained high rates of clinical and endoscopic remission in adults with moderately to severely active Crohn's disease through two years. The drugmaker said the studies evaluated patients who received either subcutaneous or...
BTU Dixie East Project Approved
BTU Dixie East Project Approved
Oct 27, 2025
VANCOUVER, BC / ACCESS Newswire ( ACCS ) / October 27, 2025 / BTU METALS CORP. ( BTUMF ) (BTU or the Company) (OTCQB:BTUMF) is pleased to announce the acquisition of the 100% interest in the newly secured Dixie East Project, a large and strategically located land package immediately east of Kinross Gold's ( KGCRF ) world-renowned Great Bear Dixie...
Copyright 2023-2026 - www.financetom.com All Rights Reserved